1. Home
  2. KDLY vs SILO Comparison

KDLY vs SILO Comparison

Compare KDLY & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KDLY
  • SILO
  • Stock Information
  • Founded
  • KDLY 2019
  • SILO 2010
  • Country
  • KDLY United States
  • SILO United States
  • Employees
  • KDLY N/A
  • SILO N/A
  • Industry
  • KDLY
  • SILO Apparel
  • Sector
  • KDLY
  • SILO Consumer Discretionary
  • Exchange
  • KDLY NYSE
  • SILO Nasdaq
  • Market Cap
  • KDLY 5.8M
  • SILO 5.9M
  • IPO Year
  • KDLY 2024
  • SILO N/A
  • Fundamental
  • Price
  • KDLY $0.97
  • SILO $0.92
  • Analyst Decision
  • KDLY
  • SILO
  • Analyst Count
  • KDLY 0
  • SILO 0
  • Target Price
  • KDLY N/A
  • SILO N/A
  • AVG Volume (30 Days)
  • KDLY 404.5K
  • SILO 201.3K
  • Earning Date
  • KDLY 11-12-2024
  • SILO 11-12-2024
  • Dividend Yield
  • KDLY N/A
  • SILO N/A
  • EPS Growth
  • KDLY N/A
  • SILO N/A
  • EPS
  • KDLY N/A
  • SILO N/A
  • Revenue
  • KDLY $2,875,400.00
  • SILO $72,102.00
  • Revenue This Year
  • KDLY N/A
  • SILO $1.86
  • Revenue Next Year
  • KDLY N/A
  • SILO N/A
  • P/E Ratio
  • KDLY N/A
  • SILO N/A
  • Revenue Growth
  • KDLY N/A
  • SILO N/A
  • 52 Week Low
  • KDLY $0.78
  • SILO $0.84
  • 52 Week High
  • KDLY $4.20
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • KDLY N/A
  • SILO 36.36
  • Support Level
  • KDLY N/A
  • SILO $1.05
  • Resistance Level
  • KDLY N/A
  • SILO $1.21
  • Average True Range (ATR)
  • KDLY 0.00
  • SILO 0.12
  • MACD
  • KDLY 0.00
  • SILO -0.03
  • Stochastic Oscillator
  • KDLY 0.00
  • SILO 3.51

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: